Prolonged time to surgery after neoadjuvant chemoradiotherapy increases histopathological response without affecting survival in patients with esophageal or junctional cancer.

J. Shapiro; P. van Hagen; H.F. Lingsma; B.P.L. Wijnhoven; K. Biermann; F.J.W. ten Kate; E.W. Steyerberg; A. van der Gaast; x CROSS Study Group; J.J.B. van Lanschot

Prolonged time to surgery after neoadjuvant chemoradiotherapy increases histopathological response without affecting survival in patients with esophageal or junctional cancer.

Translated title of the contribution: Prolonged time to surgery after neoadjuvant chemoradiotherapy increases histopathological response without affecting survival in patients with esophageal or junctional cancer.

J. Shapiro, P. van Hagen, H.F. Lingsma, B.P.L. Wijnhoven, K. Biermann, F.J.W. ten Kate, E.W. Steyerberg, A. van der Gaast, x CROSS Study Group, J.J.B. van Lanschot

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Prolonged time to surgery after neoadjuvant chemoradiotherapy increases histopathological response without affecting survival in patients with esophageal or junctional cancer.
Original language	Undefined/Unknown
Pages (from-to)	807-814
Number of pages	8
Journal	Annals of Surgery
Volume	260
Issue number	5
Publication status	Published - 2014

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/25379852

Cite this

Shapiro, J., van Hagen, P., Lingsma, H. F., Wijnhoven, B. P. L., Biermann, K., ten Kate, F. J. W., Steyerberg, E. W., van der Gaast, A., CROSS Study Group, X., & van Lanschot, J. J. B. (2014). Prolonged time to surgery after neoadjuvant chemoradiotherapy increases histopathological response without affecting survival in patients with esophageal or junctional cancer. Annals of Surgery, 260(5), 807-814. http://www.ncbi.nlm.nih.gov/pubmed/25379852

@article{ed0d03aecdad4b859602cad3f5505168,

title = "Prolonged time to surgery after neoadjuvant chemoradiotherapy increases histopathological response without affecting survival in patients with esophageal or junctional cancer.",

author = "J. Shapiro and {van Hagen}, P. and H.F. Lingsma and B.P.L. Wijnhoven and K. Biermann and {ten Kate}, F.J.W. and E.W. Steyerberg and {van der Gaast}, A. and {CROSS Study Group}, x and {van Lanschot}, J.J.B.",

year = "2014",

language = "Undefined/Unknown",

volume = "260",

pages = "807--814",

journal = "Annals of Surgery",

issn = "0003-4932",

publisher = "Lippincott Williams & Wilkins",

number = "5",

}

Shapiro, J, van Hagen, P, Lingsma, HF, Wijnhoven, BPL, Biermann, K, ten Kate, FJW, Steyerberg, EW, van der Gaast, A, CROSS Study Group, X & van Lanschot, JJB 2014, 'Prolonged time to surgery after neoadjuvant chemoradiotherapy increases histopathological response without affecting survival in patients with esophageal or junctional cancer.', Annals of Surgery, vol. 260, no. 5, pp. 807-814. <http://www.ncbi.nlm.nih.gov/pubmed/25379852>

TY - JOUR

T1 - Prolonged time to surgery after neoadjuvant chemoradiotherapy increases histopathological response without affecting survival in patients with esophageal or junctional cancer.

AU - Shapiro, J.

AU - van Hagen, P.

AU - Lingsma, H.F.

AU - Wijnhoven, B.P.L.

AU - Biermann, K.

AU - ten Kate, F.J.W.

AU - Steyerberg, E.W.

AU - van der Gaast, A.

AU - CROSS Study Group, x

AU - van Lanschot, J.J.B.

PY - 2014

Y1 - 2014

M3 - Article

SN - 0003-4932

VL - 260

SP - 807

EP - 814

JO - Annals of Surgery

JF - Annals of Surgery

IS - 5

ER -